|
 |
Aids VaccineThis page contains recent news articles, when available, and an overview of Aids Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.News: Aids Vaccine msnbc.comWASHINGTON - The failure of an experimental AIDS vaccine trial two years ago may have been caused by the common cold virus. The vaccine was intended to ... Cold virus may have caused 2007 AIDS vaccine trial failure - Nov 18, 2009 Los Angeles Times...s STEP trial of an experimental AIDS vaccine, which was terminated prematurely in 2007 when it became apparent that the vaccine seemed to increase the ... AIDS Vaccine Investment Is Paying Dividends - Oct 29, 2009 Huffington Post (blog)...of the Joint United Nations Programme on HIV/AIDS (UNAIDS) and Seth Berkley, the President and Chief Executive of the International AIDS Vaccine Initiative. Atlantis heads to space station - Nov 16, 2009 Washington PostAssociated Press The failure of an experimental AIDS vaccine trial two years ago may have been caused by the common cold virus, researchers have concluded. ... Time's Top 2009 Inventions Places Natal Above AIDS Vaccine - Nov 12, 2009 Gamespy.comApparently editors at Time think untested gaming peripheral Project Natal is a better invention than an AIDS vaccine that ... Kenya's Majengo prostitutes - Nov 21, 2009 postzambia.comBut recently a group of prostitutes thought to be immune to HIV became infected, causing dismay to scientists hoping to develop an AIDS vaccine. ... AIDS Vaccine Beat Out By Xbox's Natal In Time's "Best Inventions of 2009" (MSFT) - Nov 12, 2009 The Business InsiderEnding the worldwide AIDS epidemic would be awesome, but have you seen the demos of Microsoft's controller-free gaming system? The top spot went to NASA's ... AIDS: Panel Warns That Without New Direction, Epidemic Will Remain Out of ... - Nov 2, 2009 New York TimesThe lead author, Robert Hecht, an economist and former policymaker at the United Nations and the International AIDS Vaccine Initiative, predicted that by ... FDA Grants GeoVax Labs, Inc. Request For Pre-IND Meeting - Nov 17, 2009 PR Newswire (press release)GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to ... Viral Vector Fingered in Failed HIV Vaccine - Nov 17, 2009 Visit BulgariaThe failure of an experimental AIDS vaccine trial two years ago may have been caused by the common cold virus. Researchers suggest the failure of an ... GenVec Signs New Contract to Support HIV and Influenza Vaccine Development - Nov 5, 2009 ReutersEstablished by former President Bill Clinton as part of an initiative to develop an AIDS vaccine, the VRC is a unique venture within the NIH intramural ... Supercomputer hunts HIV vaccine targets - Oct 29, 2009 United Press InternationalResearchers at the US Department of Energy's Los Alamos National Laboratory, as part of the International Center for HIV/AIDS Vaccine Immunology Consortium, ... 'Elite controllers' offer hope in fight against HIV-Aids - Nov 4, 2009 SowetanMany researchers involved in the study presented what they have discovered so far at this week's International AIDS Vaccine Conference in Paris. ... Scientists Explain Binding Action Of 2 Key HIV Antibodies; Could Lead To New ... - Nov 10, 2009 Science Daily (press release)The study was funded by a Collaboration for AIDS Vaccine Discovery grant to Duke and Harvard from the Bill and Melinda Gates Foundation and grants from the ... Targeted Genetics Corporation Reports Third Quarter 2009 Financial Results - Nov 16, 2009 WELT ONLINEThis increase in revenue was partially offset by decreases in year-to-date 2009 revenue for the HIV/AIDS vaccine project, as 2008 results included revenue ... Also in Global Health News: HIV/AIDS grant giving; Africa's water resources ... - Nov 19, 2009 News-Medical.netAccording to the Chronicle of Philanthropy, "the coalition is urging foundations to step up their support for HIV/AIDS vaccine research, prevention, ... AIDS Grant Making Grows - Nov 17, 2009 Chronicle of Philanthropy (subscription)In a new report, the coalition is urging foundations to step up their support for HIV/AIDS vaccine research, prevention, and other projects, ... Sign Up For Our Free Newsletter and Make Money!! SKGO,PBME,TSHO,OPSY,GOVX,ZYXI - Nov 19, 2009 TMC NetGeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to ... Global Fund approves $2.4 bn to fight AIDS, TB, malaria - Nov 12, 2009 Gaea TimesSeptember 24th, 2009 Summary Box: Results out on AIDS vaccine testTHE STUDY: The world's largest test of a potential AIDS vaccine, sponsored by the US Army ... Trubion co-founder out in shake-up; PolyMedix garners $21M for mid-stage trials; - Nov 17, 2009 FierceBiotechReport > Two years ago the revelation that Merck's experimental AIDS vaccine actually increased the risk of infection among the people who volunteered for a ... WHO: AIDS leading cause of death, disease for women of child bearing age - Nov 9, 2009 Gaea TimesJuly 20th, 2009 South Africa begins AIDS vaccine trial, cuts fundsCAPE TOWN, South Africa — South Africa launched a high-profile trial of an AIDS vaccine ... Opinion: Clinton Foundation's pediatric programme - Nov 9, 2009 The New NationOf course there are some rays of hope as the USAID and its partner-International AIDS Vaccine Initiative (IAVI) has recently made a groundbreaking HIV/AIDS ... Case Studies Offer Inside Look at Effective Ways to Address Global Health ... - Nov 20, 2009 PR Newswire (press release)...are success stories, others are works in progress," said Labeeb Abboud, Senior Vice President & General Counsel, International AIDS Vaccine Initiative. ... Mission Improbable: A Concise and... - Oct 30, 2009 Science NowThe media's varied interpretations of the Thai AIDS vaccine study's results reflect the widespread confusion over the meaning of statistical significance. ... Will Anyone in Their Right Mind Actually Buy Into These Three New Vaccines? - Nov 8, 2009 Lew Rockwell...by Joseph Mercola A storm has erupted over the announcement last month that an experimental AIDS vaccine tested in Thailand proved ... New HIV Therapeutic Vaccine Provides Positive Results In Initial Clinical Trials - Oct 30, 2009 The AIDS Beacon (blog)...results of a Phase 2a trial of AGS-004, a personalized immunotherapy candidate, during two presentations at the AIDS Vaccine 2009 conference in Paris. ... Help Is Available For Smokers Who Want To Quit: A Message From Dr. Howard Koh - Nov 20, 2009 Medical News Today (press release)...health promotion, the reduction of health disparities, women's and minority health, HIV/AIDS, vaccine programs, physical fitness and sports, bioethics, ... Roadrunner supercomputer used to generate biggest HIV evolutionary tree - Nov 2, 2009 HealthJockey.comSupporting Los Alamos National Laboratory's function in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) association, by means of Roadrunner ... HPV jab girls 'more cautious about sex' - Oct 27, 2009 India Business Blog (blog)AIDS vaccine hailed as 'historic milestone' London, Sept 24 (ANI): An experimental AIDS vaccine has been found effective in reducing HIV infection by more ... TIME ranks univ. invention among best of the year - Nov 17, 2009 Diamondback Online50 best inventions of 2009 — beating a possible AIDS vaccine, an electric eye that could give blind people partial vision and a mind-reading machine. ... Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 - Nov 19, 2009 Science Magazine (subscription)3 Departments of Immunology and Microbial Science and International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, ... Ares 1 rocket tips tuna breeder out of Time top spot - Nov 17, 2009 NEWS.com.auSeas achievement to breed southern bluefin tuna in March at its Arno Bay hatchery on Eyre Peninsula, ahead of other such inventions as the AIDS vaccine. ... AP source: Fort Hood shooting suspect Army major - Nov 5, 2009 Gaea TimesDavid Petraeus, the top US September 24th, 2009 Summary Box: Results out on AIDS vaccine testTHE STUDY: The world's largest test of a potential AIDS vaccine ... Bill Gates' Plan for Fixing the World - Nov 11, 2009 Mashable (blog)He doesn't see an AIDS vaccine within the next 10 years, but thinks it's possible within the next 20. He thinks by 2025, there's a good chance that no one ... Aussies Win 'Best Invention' Award - Nov 21, 2009 Australian Migration NewsTime says it is second only to “the best and smartest and coolest thing built in 2009″ - NASA's Ares 1 rocket - and ahead of the AIDS vaccine. ... Nobel laureate to speak at Claflin - Nov 2, 2009 Orangeburg Times Democrat...facility and to introducing him to our graduate students who are engaged in HIV/AIDs research with prospects for an AIDs vaccine," Bagasra said. ... Crucell Announces Third Quarter 2009 Results - Nov 4, 2009 CNNMoney.com (press release)Promising preliminary results of the Phase I study of Crucell's HIV vaccine were presented at La Conférence AIDS Vaccine 2009 in Paris, France, showing that ... China health ministry says 2 people who received swine flu vaccine die; at ... - Nov 13, 2009 Gaea TimesSeptember 25th, 2009 US says first swine flu vaccine ready Oct. 6ATLANTA — US September 24th, 2009 Summary Box: Results out on AIDS vaccine testTHE STUDY: ... Setting the record straight on our health care legislation (Rep. Anna Eshoo) - Oct 30, 2009 The HillI want to highlight a point on which Ms. Hamsher and I are in complete agreement: "If an AIDS vaccine is found, it too will be a biologic. ... Tank-bred tuna second best invention - Nov 18, 2009 Port Lincoln TimesThe tank-bred tuna successfully beat other top inventions including the AIDS vaccine, controller-free gaming, teleportation and the electric eye. ... Well, at Least the Phone Works Fine - Nov 7, 2009 New York TimesMs. Gupta, who works on the International AIDS Vaccine Initiative, said on Tuesday that Mr. Reeder had apologized profusely on the phone and promised a ... Time's top 50 innovations for 2009 a worthy read - Nov 16, 2009 SmartPlanet.comAnd I hope the editors follow-up on which innovations over time contribute to mankind or get market traction, but it's hard to argue that the AIDs vaccine ... Sales, Stat! - Oct 28, 2009 Portfolio.comRead More VaxGen has gained little from a controversial claim that it has speeded up the search for an AIDS vaccine. Read More Overseas clinical trials are ... Chairman Gordon and Subcommittee Chairwoman Giffords Congratulate NASA on ... - Nov 16, 2009 Space Ref (press release)The Ares rockets placed before several remarkable inventions - the Smart Thermostat (#4), the AIDS vaccine (#8), and Tweeting by Thinking (#9), among others ... Jury still out on HIV vaccine results - Oct 28, 2009 Nature.com (subscription)The trial's results were published on 20 October to coincide with the AIDS vaccine meeting in Paris (S. Rerks-Ngarm et al. ... UCB plans to cut 200 jobs in Belgium, UK; Revised bids due for Swiss generics ... - Nov 17, 2009 FiercePharmaReport > Two years ago the revelation that Merck's experimental AIDS vaccine actually increased the risk of infection among the people who volunteered for a ... Largest HIV evolutionary tree created using the speedy Roadrunner supercomputer - Oct 31, 2009 TechShout! (blog)This has been done by researchers supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) ... MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New ... - Nov 7, 2009 PR-USA.net (press release)Following Dr. Oswald's presentation, the International AIDS Vaccine Initiative (IAVI), making a rare public address in Boston, will discuss its Innovation ... www.standoutstocks.com: Stocks That Stand Out For Nov. 17th, 2009 Are GOVX ... - Nov 17, 2009 Trading Markets (press release)GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to ... Indian-American uses supercomputer to make HIV evolutionary tree - Oct 28, 2009 SifyTanmoy Bhattacharya, physicist at Los Alamos National Lab, and HIV researcher Bette Korber have used samples taken by the Centre for HIV/AIDS Vaccine ... Background information on Aids Vaccine [When available] In 1984, after the confirmation of the etiological agent of AIDS by Prof. Robert Gallo, the United States Health and Human Services Secretary Margaret Heckler declared that a vaccine would be available within two years (Associated Press, 1984). However, the classical vaccination approaches that have been successful in the control of various viral diseases by priming the adaptive immunity to recognise the viral envelope proteins have failed in the case of HIV-1, as the epitopes of the viral envelope are too variable. Furthermore, the functionally important epitopes of the gp120 protein are masked by glycosylation, trimerisation and receptor-induced conformational changes making it difficult to block with neutralising antibodies. In February 2003, Vaxgen announced that their AIDSVAX vaccine was a failure in North America as there was not a statistically significant reduction of HIV infection within the study population (Francis et al., 2003). In November 2003, it also failed clinical trials in Thailand for the same reason. These vaccines both targeted gp120 and were specific for the geographical regions (Billich et al., 2001). There are two key issues that protect HIV from vaccines. Firstly, selective pressure quickly neutralised early promise; the falling off of immune response is called anergy. HIV responds rapidly to these pressures, as is recorded by the HIV Variation Project. Secondly, from human isolates it has been discovered that HIV currently has three groups of clades, M, N and O. Nine clades have been identified in M (A-G) but fewer in the others. The earliest vaccine were based on the LAI clade, which was discovered to be rare in human infections. The second problem with HIV is its attack on the immune system itself which means that, to date, no effective cell-mediated immune response has been determined. Although there have been more than 50 million infections in Africa since 1981, there have been few vaccine trials in the continent, the most severely afflicted by the pandemic. HIV-1 vaccines need to be developed for testing in Africa, as it is in this context, with the risk of infection being the greatest, that a preventative vaccine can be proved to be effective. The remarkable genetic diversity of HIV-1 strains in Africa is a major hurdle in the development of a broadly effective vaccine (McCutchan, 2000). All known HIV-1 subtypes and an array of intersubtype recombinant viruses, often in complex mosaic forms, are found throughout the continent (Peeters and Sharp, 2000). However, the major HIV-1 subtypes accounting for most infections in Africa are subtype C in southern Africa, subtypes A and D in eastern Africa, and CRF02_AG in west-central Africa (UNAIDS, 2004). Therefore, CTL and antibody responses raised by any vaccine need to be broad enough to cover this variability. The typical animal model for vaccine research is the monkey, often the macaque. The monkeys can be infected with SIV or the chimeric SHIV for research purposes. However, the well-proven route of trying to induce neutralizing antibodies by vaccination has stalled because of the great difficulty in stimulating antibodies that neutralise heterologous primary HIV isolates (Poignard et al., 1999). Some vaccines based on the virus envelope have protected chimpanzees or macaques from homologous virus challenge (Berman et al., 1990), but in clinical trials, individuals who were immunised with similar constructs became infected after later exposure to HIV-1 (Connor et al., 1998). The human body can defend itself against HIV, as work with monoclonal antibodies (MAb) has proven. That certain individuals can be asymptomatic for decades after infection is encouraging. source: Wikipedia Search the web for more resources on Aids Vaccine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
